Skip to main content
Clinical Trials/JPRN-UMIN000008371
JPRN-UMIN000008371
Completed
未知

Clinical observation study of 5-year survivals in patients with newly diagnosed acute myelogenous leukemia (AML), myelodysplastic syndromes (MDS), and chronic myelomonocytic leukemia (CMML) in Japan Adult Leukemia Study Group - JALSG AML/MDS/CMML Clinical Observational Study (JALSG-CS)-11

Japan Adult Leukemia Study Group0 sites6,100 target enrollmentJuly 20, 2012

Overview

Phase
未知
Intervention
Not specified
Conditions
Acute myelogenous leukemia (AML), myelodysplastic syndromes (MDS), and chronic myelomonocytic leukemia (CMML)
Sponsor
Japan Adult Leukemia Study Group
Enrollment
6100
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 20, 2012
End Date
January 31, 2021
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Past history of chemotherapy or stem cell transplantation in the treatment of AML, MDS, or CMM

Outcomes

Primary Outcomes

Not specified

Similar Trials